All News about Pulse Biosciences CS
Pulse Biosciences Lead Therapeutic System Scores FDA Approval For Sebaceous Hyperplasia
September 26, 2022
Via Benzinga
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022
September 21, 2022
Via Benzinga
Pulse Biosciences Reports Second Quarter 2022 Financial Results
August 10, 2022
Via Business Wire
From Pulse Biosciences
Via Business Wire
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|